Effective Treatment for Dyspareunia with Intrarosa Therapy

June. 27,2025

Discover how Intrarosa can effectively treat dyspareunia, a condition characterized by painful intercourse. This FDA-approved suppository improves vaginal tissue health by stimulating hormone production, reducing discomfort for women suffering from this often-overlooked issue. Clinical studies show significant pain relief, making it a promising treatment option. Consult your healthcare provider to explore if Intrarosa is suitable for you. An innovative solution for improving quality of life and sexual health, Intrarosa offers hope for many women experiencing dyspareunia.

Effective Treatment for Dyspareunia with Intrarosa Therapy

Effective Strategies for Managing Dyspareunia with Intrarosa

Dyspareunia, a condition that impacts many women at some stage, refers to pain during sexual activity. Many women dismiss this discomfort, believing pain during intercourse is normal, and continue engaging in intimacy despite discomfort. This condition can result from physical or psychological causes, showing symptoms like pain during penetration, burning sensations, lingering throbbing pain, or discomfort with tampon use. Often underestimated, dyspareunia can significantly affect quality of life.

Fortunately, an FDA-approved medication called Intrarosa offers relief for women experiencing moderate to severe pain caused by this condition. It mainly results from thinning and dryness of vaginal tissues, leading to discomfort during intimacy.

Intrarosa contains a synthetic steroid called prasterone (DHEA), a hormone naturally produced by adrenal glands. This inactive precursor hormone stimulates the production of estrogen and testosterone when it interacts with vaginal cells, enhancing tissue elasticity and balancing pH levels, which can lessen pain during sex.

The medication is administered as a suppository inserted into the vagina once nightly, dissolving overnight. Clinical trials involving 406 women aged 40 to 80 demonstrated notable pain reduction after 12 weeks of treatment. Intrarosa provides an innovative option for women who have not responded well to therapies like desensitization or counseling. Always consult a healthcare professional before starting any new treatment.